Cryo-Cell International Amends Credit Agreement and Extends Loan Maturities with Susser Bank
Cryo-Cell International Inc. has amended its existing credit agreement with Susser Bank, extending and modifying the terms of its corporate financing. Under the Fifth Amendment signed on October 18, 2025, the company's wholly owned subsidiary, Celle Corp., was added as a guarantor, and a security agreement was executed for the benefit of the lenders. The revolving credit facility's maturity date was extended to October 18, 2027, with the credit limit adjusted to $8 million. Additionally, the maturity date of the term loan was extended to July 29, 2032. The amendment also revised the applicable interest margins, with rates on the revolving credit and term loans set based on the Base Rate and Monthly SOFR, and a commitment fee of 0.25% per annum.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-248883), on October 23, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。